Exicure, Inc. (XCUR) Financial Ratios
11 years of historical data (2015–2025) · Healthcare · Biotechnology
EV/EBITDA
N/A
—
5yr avg: 1011.64
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
↑
4.39
↓-43% vs avg
5yr avg: 7.69
30Y Low1.8·High34.8
ROE
↑
-92.5%
↓+31% vs avg
5yr avg: -135.0%
30Y Low-198%·High-20%
Debt/EBITDA
N/A
—
5yr avg: 292.24
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
XCUR Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Exicure, Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $17M | $34M | $83M | $23M | $27M | $90M | $772M | $825M | $729M | — | — |
| Enterprise Value | $14M | $31M | $77M | $29M | $25M | $70M | $763M | $782M | $708M | — | — |
| P/E Ratio → | -3.47 | — | — | — | — | — | — | — | — | — | — |
| P/S Ratio | — | — | 166.90 | — | 0.92 | — | 46.45 | 636.35 | 6178.37 | — | — |
| P/B Ratio | 4.39 | 8.69 | 12.32 | 7.67 | 1.78 | 7.97 | 12.55 | 10.21 | 34.80 | — | — |
| P/FCF | — | — | — | — | — | — | — | 3509.39 | — | — | — |
| P/OCF | — | — | — | — | — | — | — | 626.20 | — | — | — |
P/E links to full P/E history page with 30-year chart
XCUR EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | — | 153.76 | — | 0.88 | — | 45.94 | 603.06 | 5997.50 | — | — |
| EV / EBITDA | — | — | — | — | 1011.64 | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | 3325.79 | — | — | — |
XCUR Profitability
Margins and return-on-capital ratios measuring operating efficiency
A negative ROE of -92.5% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | — | — | 100.0% | — | 93.6% | 100.0% | -93.2% | 100.0% | -11865.3% | -34.6% | -1218.4% |
| Operating Margin | — | — | -2446.4% | — | -6.4% | 12950.1% | -153.1% | -2053.8% | -18490.7% | -107.1% | -1560.0% |
| Net Profit Margin | — | — | -1940.2% | — | -9.0% | 13271.6% | -148.5% | -2029.6% | -18994.1% | -113.3% | -1635.2% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -92.5% | -92.5% | -197.9% | -188.4% | -19.7% | -176.3% | -34.7% | -51.7% | -109.5% | -98.2% | -163.9% |
| ROA | -34.0% | -34.0% | -72.8% | -96.9% | -5.9% | -77.6% | -22.9% | -36.5% | -77.6% | -44.4% | -84.3% |
| ROIC | -2734.3% | -2734.3% | -202.1% | -99.8% | -55.2% | -211.6% | -42.1% | -107.3% | — | — | — |
| ROCE | -91.4% | -91.4% | -116.2% | -97.5% | -7.0% | -106.5% | -29.8% | -48.0% | -83.4% | -61.1% | -121.1% |
XCUR Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
The company holds a net cash position — cash of $4M exceeds total debt of $176000, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.04 | 0.04 | 0.88 | 2.20 | 0.49 | 1.31 | 0.40 | 0.07 | 0.24 | 0.24 | 2.31 |
| Debt / EBITDA | — | — | — | — | 292.24 | — | — | — | — | — | — |
| Net Debt / Equity | — | -0.91 | -0.97 | 1.93 | -0.09 | -1.77 | -0.14 | -0.53 | -1.02 | -1.05 | -5.70 |
| Net Debt / EBITDA | — | — | — | — | -50.84 | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — | -183.59 | — | — | — |
| Interest Coverage | -10117.00 | -10117.00 | -537.50 | — | -2.99 | -36.91 | -42.05 | -32.46 | -32.35 | -12.85 | -22.40 |
Net cash position: cash ($4M) exceeds total debt ($176000)
XCUR Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.19x means Exicure, Inc. can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has improved from 0.81x to 1.19x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.19 | 1.19 | 4.45 | 0.81 | 6.13 | 1.28 | 6.29 | 3.63 | 13.54 | 8.24 | 1.65 |
| Quick Ratio | 1.19 | 1.19 | 4.45 | 0.81 | 6.13 | 1.28 | 6.29 | 3.63 | 13.22 | 8.24 | 1.65 |
| Cash Ratio | 0.96 | 0.96 | 4.07 | 0.33 | 5.23 | 1.15 | 5.98 | 3.56 | 12.86 | 7.68 | 1.61 |
| Asset Turnover | — | — | 0.03 | — | 1.24 | -0.01 | 0.17 | 0.01 | 0.00 | 0.34 | 0.05 |
| Inventory Turnover | — | — | — | — | — | — | — | — | 21.86 | — | — |
| Days Sales Outstanding | — | — | 380.33 | — | — | — | 0.24 | 9.86 | 9.28 | 1.13 | 5.28 |
XCUR Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Exicure, Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | 0.0% | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Shares Outstanding | — | $6M | $6M | $8M | $5M | $3M | $3M | $2M | $1M | $1M | $1M |
Peer Comparison
Compare XCUR with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 XCURYou | $17M | -3.5 | — | — | — | — | -92.5% | -2734.3% | — |
 SRPT | $2B | -2.5 | — | — | 59.9% | -29.9% | -53.5% | -31.4% | — |
 ARWR | $12B | -6721.3 | 95.6 | 73.6 | 100.0% | 11.9% | -0.5% | 9.3% | 3.0 |
 NTLA | $2B | -4.1 | — | — | 76.5% | -651.7% | -53.5% | -44.0% | — |
 BEAM | $4B | -43.9 | — | — | 84.0% | -274.6% | -8.1% | -31.1% | — |
 EDIT | $274M | -1.6 | — | — | 100.0% | -245.2% | -198.1% | — | — |
 CRSP | $5B | -8.4 | — | — | -6537.0% | -16191.4% | -30.2% | -22.3% | — |
 IONS | $13B | -31.9 | — | — | 98.3% | -40.5% | -70.7% | -12.8% | — |
 REGN | $64B | 14.8 | 15.3 | 15.6 | 85.4% | 24.9% | 14.9% | 8.9% | 0.7 |
 MRNA | $24B | -8.2 | — | — | 55.3% | -158.1% | -28.9% | -26.1% | — |
 WAVE | $52M | -13.8 | — | — | -610.5% | -8416.0% | -53.9% | -205.2% | — |
| Healthcare Median | — | 22.1 | 14.2 | 18.4 | 63.9% | -4.4% | -33.2% | -11.7% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 11 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
XCUR — Frequently Asked Questions
Quick answers to the most common questions about buying XCUR stock.
What is Exicure, Inc.'s P/E ratio?
Exicure, Inc.'s current P/E ratio is -3.5x. This places it at the 50th percentile of its historical range.
What is Exicure, Inc.'s ROE?
Exicure, Inc.'s return on equity (ROE) is -92.5%. The historical average is -109.5%.
Is XCUR stock overvalued?
Based on historical data, Exicure, Inc. is trading at a P/E of -3.5x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.